TPTX

Bristol-Myers to Buy Turning Point Therapeutics for $4.1 Billion

HS 03/06/2022

Bristol-Myers Squibb Co. said it will acquire biotechnology company Turning Point Therapeutics Inc. TPTX 116.76% for $4.1 billion, an effort...

Many worlds of AI: For investors, the implications are significant – The Times of India

HS 24/02/2026

Four years into the Ukraine war, is Europe ready for its own army?

HS 24/02/2026

He hesitated to take the CEO job. Here’s why Schneider Electric’s Olivier Blum ultimately said yes — and plans to stay

HS 23/02/2026

1,000-year-old gold tomb found in Panama shows ancient treasures and powerful leaders | World News – The Times of India

HS 23/02/2026

Australia vs India, 1st Women's ODI Live Score and Updates from Brisbane

HS 23/02/2026